GLEZISIM 10MG/40 MG TBL NOB 28

What is the maximum co-payment for GLEZISIM?

If the insurance company contributes, the maximum co-payment is 153,86 Kč. The maximum pharmacy price is 1 285,11 Kč. A pharmacy may provide the medicine for a lower price, but not for a higher price.

Does the medicine have reimbursement from public health insurance?

Yes, but check the specialization of the prescribing physician below (a so-called non-delegable prescription).

Does GLEZISIM have a counted co-payment set?

Yes, the medicine has a counted co-payment of 11,00 Kč. Learn more about the protective limit here.

How much does the insurance company pay for one dispensed reimbursed pack?

1 131,25 Kč.

Does the insurance company pay a higher amount in some cases?

No, the medicine has no increased reimbursement.

Does the medicine have an indication restriction?

Ezetimib v kombinaci se simvastatinem je hrazen u pacientů, u kterých nelze dosáhnout cílových hodnot LDL-cholesterolu atorvastatinem 20,00 mg/den, simvastatinem 40,00 mg/den, fluvastatinem 80,00 mg/den, lovastatinem 80,00 mg/den a pravastatinem 40,00 mg/den nebo rosuvastatinem 20,00 mg/den. Cílová hodnota je stanovena u osob bez manifestace aterosklerózy či diabetu na 3,00 mmol/l a u osob s manifestací aterosklerózy či diabetem na 2,50 mmol/l.

Is it available without a medical prescription?

No, the medicine cannot be obtained without a prescription.

Which medical specialist may prescribe GLEZISIM?

cardiology, pediatric cardiology, angiology
internal medicine
diabetology
specialized center for the treatment of hyperlipoproteinemia

What is the composition of GLEZISIM?

Ezetimib (10 mg), simvastatin (40 mg), monohydrát laktosy, neznámá látka s kódem 3755, hypromelosa, sodná sůl kroskarmelosy, propyl-gallát, neznámá látka s kódem 3803, monohydrát kyseliny citronové, natrium-lauryl-sulfát, magnesium-stearát. More information about the composition can be found in the SPC, section 6.1.

Where can I find information about correct use of the medicine?

Which medicines are similar to GLEZISIM?

The medicine belongs to ATC group C10BA02 – SIMVASTATIN A EZETIMIB. Medicines with the same active substance can be found here.

Who manufactures GLEZISIM?

Glenmark Pharmaceuticals s.r.o., Praha (CZ)

Is the medicine in shortage?

The latest report from the manufacturer is from 21. 10. 2025. Production was interrupted as of 24. 10. 2025. The stated reason was: Výrobní důvody.
Resumption of supply is expected 28. 2. 2026
The manufacturer lists medicines with the following code as a potential substitute:
The product has no substitute listed.Note provided: LP se samostatně registrovanými léčivými látkami.